DNMT1 and DNMT3b cooperate to silence genes in human cancer cells

Nature
Ina RheeBert Vogelstein

Abstract

Inactivation of tumour suppressor genes is central to the development of all common forms of human cancer. This inactivation often results from epigenetic silencing associated with hypermethylation rather than intragenic mutations. In human cells, the mechanisms underlying locus-specific or global methylation patterns remain unclear. The prototypic DNA methyltransferase, Dnmt1, accounts for most methylation in mouse cells, but human cancer cells lacking DNMT1 retain significant genomic methylation and associated gene silencing. We disrupted the human DNMT3b gene in a colorectal cancer cell line. This deletion reduced global DNA methylation by less than 3%. Surprisingly, however, genetic disruption of both DNMT1 and DNMT3b nearly eliminated methyltransferase activity, and reduced genomic DNA methylation by greater than 95%. These marked changes resulted in demethylation of repeated sequences, loss of insulin-like growth factor II (IGF2) imprinting, abrogation of silencing of the tumour suppressor gene p16INK4a, and growth suppression. Here we demonstrate that two enzymes cooperatively maintain DNA methylation and gene silencing in human cancer cells, and provide compelling evidence that such methylation is essential for optimal ...Continue Reading

References

Dec 6, 1994·Proceedings of the National Academy of Sciences of the United States of America·R JüttermannR Jaenisch
Apr 22, 1993·Nature·S RainierA P Feinberg
Sep 3, 1996·Proceedings of the National Academy of Sciences of the United States of America·J G HermanS B Baylin
May 1, 1997·Current Biology : CB·Z Siegfried, H Cedar
Dec 10, 1999·Cell·A P Bird, A P Wolffe
Feb 23, 2000·The Journal of Clinical Investigation·B Tycko
Feb 26, 2000·Carcinogenesis·K D Robertson, P A Jones
Mar 24, 2000·Trends in Genetics : TIG·S B Baylin, J G Herman
Sep 27, 2000·Human Molecular Genetics·T H Bestor
May 18, 2001·Nature·B A Ponder

❮ Previous
Next ❯

Citations

Jul 17, 2008·Comparative and Functional Genomics·Andrew J Mungall
Jan 12, 2005·The Journal of Pathology·Manel Esteller
Jan 16, 2007·Cellular and Molecular Life Sciences : CMLS·J Espada, M Esteller
Aug 28, 2010·Cellular and Molecular Life Sciences : CMLS·V A Blomen, J Boonstra
Jun 16, 2007·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Yeonjoo JungTae-You Kim
Sep 3, 2008·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Jinah ParkYung-Jue Bang
Jul 22, 2006·Journal of Hepato-biliary-pancreatic Surgery·Norihiro Sato, Michael Goggins
Jun 29, 2010·Surgery Today·Makoto Suzuki, Ichiro Yoshino
May 22, 2009·Breast Cancer Research and Treatment·Madhavi BillamNancy E Davidson
Dec 21, 2010·Breast Cancer Research and Treatment·Nguyen Thi Thuy PhuongKeon Wook Kang
Oct 12, 2007·Cell Biology and Toxicology·Yongmei XiaoGeorge Hammons
Dec 18, 2004·Plant Molecular Biology·Werner AufsatzMarjori Matzke
Jun 20, 2008·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Shi ZuoShengquan Zou
Aug 22, 2008·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Mashaal DhirNita Ahuja
Apr 25, 2012·Chinese Journal of Integrative Medicine·Xiao-ying Tian, Liang Liu
May 4, 2013·Current Diabetes Reports·Samuel T Keating, Assam El-Osta
Mar 20, 2013·Cell Biochemistry and Biophysics·Haleh Akhavan-Niaki, Ali Akbar Samadani
Jan 13, 2012·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Joo Mi YiNita Ahuja
Mar 17, 2004·Biochimica Et Biophysica Acta·Marjori MatzkeAntonius J M Matzke
Mar 12, 2004·The Journal of Surgical Research·David S Schrump
Dec 31, 2003·Nutrition·Mark D Garfinkel, Douglas M Ruden
Jul 27, 2002·Cancer Letters·Laura J Rush, Christoph Plass
Feb 5, 2003·Cancer Letters·Kenneth P Nephew, Tim Hui-Ming Huang
Mar 15, 2003·Cancer Letters·Yae KanaiSetsuo Hirohashi
Aug 23, 2002·Seminars in Cancer Biology·Stephen B Baylin
Jan 14, 2003·Seminars in Cell & Developmental Biology·Richard R Meehan
Aug 30, 2002·The International Journal of Biochemistry & Cell Biology·Peter NeumeisterRichard G Pestell
Oct 31, 2003·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Melanie Ehrlich
Oct 31, 2003·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Sriharsa Pradhan, Pierre-Olivier Esteve
Oct 31, 2003·Clinical Immunology : the Official Journal of the Clinical Immunology Society·David R Fitzpatrick, Christopher B Wilson
Jan 26, 2011·Expert Reviews in Molecular Medicine·Santiago Uribe-LewisAdele Murrell
Oct 1, 2011·Journal of Medicinal Chemistry·Sabrina CastellanoGianluca Sbardella
Jul 16, 2008·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Georges J NettoAngelo M De Marzo
Apr 28, 2007·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Anshu AgrawalDevendra K Agrawal
Dec 17, 2005·Nature·Emmanuelle ViréFrançois Fuks
Dec 13, 2005·Nature Clinical Practice. Oncology·Stephen B Baylin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.